APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Growth and Trends Forecast to 2032

24 December 2025117 pages

Choose your research edition.

Industry ResearchLiposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Liposomes and Lipid Nanoparticles Pharmaceutical Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Liposomes and Lipid Nanoparticles Pharmaceutical Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liposomes and Lipid Nanoparticles Pharmaceutical Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents include Evonik, MicroNano Biologics, GenScript, WuXi STA, Wacker, Precigenome, Polymun Scientific, Nippon Fine Chemical and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liposomes and Lipid Nanoparticles Pharmaceutical Reagents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Company

Evonik

MicroNano Biologics

GenScript

WuXi STA

Wacker

Precigenome

Polymun Scientific

Nippon Fine Chemical

Merck KGaA

Genevant Sciences

Cytiva

Croda International

Creative Biolabs

Corden Pharma

Catalent

Acuitas Therapeutics

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Segment by Type

Small Molecule/Peptide Delivery Lipids

siRNA-Delivery Lipids

mRNA-Delivery Lipids

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Segment by Application

Vaccine

Gene Therapy

Cancer Treatment

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Small Molecule/Peptide Delivery Lipids Table 2. Major Company of siRNA-Delivery Lipids Table 3. Major Company of mRNA-Delivery Lipids Table 4. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 6. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Type (2021-2026) Table 7. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (US$ Million) Table 8. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Type (2021-2026) Table 9. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2021-2026) & (USD/unit) Table 10. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (units) Table 11. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Type (2027-2032) Table 12. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (US$ Million) Table 13. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Type (2027-2032) Table 14. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2027-2032) & (USD/unit) Table 15. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 16. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 18. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 20. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 22. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 24. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (US$ Million) Table 25. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Trends Table 26. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Drivers Table 27. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Opportunities and Challenges Table 28. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Restraints Table 29. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Company (2021-2026) Table 31. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Company (2021-2026) & (units) Table 32. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Share by Company (2021-2026) Table 33. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Major Company Production Sites and Headquarters Table 36. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Company, Product Type & Application Table 37. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2021-2026) & (units) Table 42. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Region (2021-2026) Table 43. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2021-2026) & (US$ Million) Table 44. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Region (2021-2026) Table 45. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2027-2032) & (units) Table 47. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Region (2027-2032) Table 48. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2027-2032) & (US$ Million) Table 49. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Region (2027-2032) Table 50. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 53. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Application (2021-2026) Table 54. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (US$ Million) Table 55. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Application (2021-2026) Table 56. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2021-2026) & (USD/unit) Table 57. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (units) Table 58. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Application (2027-2032) Table 59. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (US$ Million) Table 60. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Application (2027-2032) Table 61. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2027-2032) & (USD/unit) Table 62. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 63. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 65. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 67. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 69. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 71. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (US$ Million) Table 72. Evonik Company Information Table 73. Evonik Business Overview Table 74. Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 76. Evonik Recent Development Table 77. MicroNano Biologics Company Information Table 78. MicroNano Biologics Business Overview Table 79. MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 81. MicroNano Biologics Recent Development Table 82. GenScript Company Information Table 83. GenScript Business Overview Table 84. GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 86. GenScript Recent Development Table 87. WuXi STA Company Information Table 88. WuXi STA Business Overview Table 89. WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 91. WuXi STA Recent Development Table 92. Wacker Company Information Table 93. Wacker Business Overview Table 94. Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 96. Wacker Recent Development Table 97. Precigenome Company Information Table 98. Precigenome Business Overview Table 99. Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 101. Precigenome Recent Development Table 102. Polymun Scientific Company Information Table 103. Polymun Scientific Business Overview Table 104. Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 106. Polymun Scientific Recent Development Table 107. Nippon Fine Chemical Company Information Table 108. Nippon Fine Chemical Business Overview Table 109. Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 111. Nippon Fine Chemical Recent Development Table 112. Merck KGaA Company Information Table 113. Merck KGaA Business Overview Table 114. Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 116. Merck KGaA Recent Development Table 117. Genevant Sciences Company Information Table 118. Genevant Sciences Business Overview Table 119. Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 121. Genevant Sciences Recent Development Table 122. Cytiva Company Information Table 123. Cytiva Business Overview Table 124. Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 126. Cytiva Recent Development Table 127. Croda International Company Information Table 128. Croda International Business Overview Table 129. Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 131. Croda International Recent Development Table 132. Creative Biolabs Company Information Table 133. Creative Biolabs Business Overview Table 134. Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 136. Creative Biolabs Recent Development Table 137. Corden Pharma Company Information Table 138. Corden Pharma Business Overview Table 139. Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 141. Corden Pharma Recent Development Table 142. Catalent Company Information Table 143. Catalent Business Overview Table 144. Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 146. Catalent Recent Development Table 147. Acuitas Therapeutics Company Information Table 148. Acuitas Therapeutics Business Overview Table 149. Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 151. Acuitas Therapeutics Recent Development Table 152. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 153. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 154. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Country (2021-2026) Table 155. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032) & (units) Table 156. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share Forecast by Country (2027-2032) Table 157. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026) & (US$ Million) Table 159. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country (2021-2026) Table 160. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share Forecast by Country (2027-2032) Table 162. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 163. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 164. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Country (2021-2026) Table 165. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032) & (units) Table 166. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share Forecast by Country (2027-2032) Table 167. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026) & (US$ Million) Table 169. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country (2021-2026) Table 170. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 174. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Country (2021-2026) Table 175. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032) & (units) Table 176. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026) & (US$ Million) Table 179. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country (2021-2026) Table 180. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share Forecast by Country (2027-2032) Table 182. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 183. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 184. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Country (2021-2026) Table 185. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032) & (units) Table 186. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share Forecast by Country (2027-2032) Table 187. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026) & (US$ Million) Table 189. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country (2021-2026) Table 190. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 194. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Country (2021-2026) Table 195. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032) & (units) Table 196. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026) & (US$ Million) Table 199. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country (2021-2026) Table 200. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share Forecast by Country (2027-2032) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Distributors List Table 205. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Image Figure 2. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size (2021-2032) & (US$ Million) Figure 4. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (2021-2032) & (units) Figure 5. Small Molecule/Peptide Delivery Lipids Image Figure 6. Global Small Molecule/Peptide Delivery Lipids Sales YoY Growth (2021-2032) & (units) Figure 7. siRNA-Delivery Lipids Image Figure 8. Global siRNA-Delivery Lipids Sales YoY Growth (2021-2032) & (units) Figure 9. mRNA-Delivery Lipids Image Figure 10. Global mRNA-Delivery Lipids Sales YoY Growth (2021-2032) & (units) Figure 11. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Type 2025 VS 2032 Figure 13. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Type in 2025 Figure 14. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Type in 2025 Figure 15. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Type in 2025 Figure 16. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Type in 2025 Figure 19. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Vaccine Image Figure 26. Global Vaccine Sales YoY Growth (2021-2032) & (units) Figure 27. Gene Therapy Image Figure 28. Global Gene Therapy Sales YoY Growth (2021-2032) & (units) Figure 29. Cancer Treatment Image Figure 30. Global Cancer Treatment Sales YoY Growth (2021-2032) & (units) Figure 31. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Application 2025 VS 2032 Figure 33. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Application in 2025 Figure 34. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Application in 2025 Figure 35. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Application in 2025 Figure 36. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Application in 2025 Figure 39. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share in Value by Application in 2025 Figure 43. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 60. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule/Peptide Delivery Lipids
  • siRNA-Delivery Lipids
  • mRNA-Delivery Lipids
Applications
  • Vaccine
  • Gene Therapy
  • Cancer Treatment
Companies covered
  • Evonik
  • MicroNano Biologics
  • GenScript
  • WuXi STA
  • Wacker
  • Precigenome
  • Polymun Scientific
  • Nippon Fine Chemical
  • Merck KGaA
  • Genevant Sciences
  • Cytiva
  • Croda International
  • Creative Biolabs
  • Corden Pharma
  • Catalent
  • Acuitas Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Type
  6. 1.3.1 Small Molecule/Peptide Delivery Lipids
  7. 1.3.2 siRNA-Delivery Lipids
  8. 1.3.3 mRNA-Delivery Lipids
  9. 1.4 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Type
  10. 1.4.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Trends
  2. 2.2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Drivers
  3. 2.3 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Opportunities and Challenges
  4. 2.4 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2026)
  2. 3.2 Global Top Players by Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (2021-2026)
  3. 3.3 Global Top Players by Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price (2021-2026)
  4. 3.4 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Major Company Production Sites & Headquarters
  6. 3.6 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Company, Product Type & Application
  7. 3.7 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Tier 1, Tier 2, and Tier 3
4 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Regional Status and Outlook
  1. 4.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Historic Market Size by Region
  3. 4.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Forecasted Market Size by Region
  7. 4.3.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents by Application
  1. 5.1 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Application
  2. 5.1.1 Vaccine
  3. 5.1.2 Gene Therapy
  4. 5.1.3 Cancer Treatment
  5. 5.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Application
  6. 5.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Evonik
  2. 6.1.1 Evonik Company Information
  3. 6.1.2 Evonik Business Overview
  4. 6.1.3 Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  6. 6.1.5 Evonik Recent Developments
  7. 6.2 MicroNano Biologics
  8. 6.2.1 MicroNano Biologics Company Information
  9. 6.2.2 MicroNano Biologics Business Overview
  10. 6.2.3 MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  12. 6.2.5 MicroNano Biologics Recent Developments
  13. 6.3 GenScript
  14. 6.3.1 GenScript Company Information
  15. 6.3.2 GenScript Business Overview
  16. 6.3.3 GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  18. 6.3.5 GenScript Recent Developments
  19. 6.4 WuXi STA
  20. 6.4.1 WuXi STA Company Information
  21. 6.4.2 WuXi STA Business Overview
  22. 6.4.3 WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  24. 6.4.5 WuXi STA Recent Developments
  25. 6.5 Wacker
  26. 6.5.1 Wacker Company Information
  27. 6.5.2 Wacker Business Overview
  28. 6.5.3 Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  30. 6.5.5 Wacker Recent Developments
  31. 6.6 Precigenome
  32. 6.6.1 Precigenome Company Information
  33. 6.6.2 Precigenome Business Overview
  34. 6.6.3 Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  36. 6.6.5 Precigenome Recent Developments
  37. 6.7 Polymun Scientific
  38. 6.7.1 Polymun Scientific Company Information
  39. 6.7.2 Polymun Scientific Business Overview
  40. 6.7.3 Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  42. 6.7.5 Polymun Scientific Recent Developments
  43. 6.8 Nippon Fine Chemical
  44. 6.8.1 Nippon Fine Chemical Company Information
  45. 6.8.2 Nippon Fine Chemical Business Overview
  46. 6.8.3 Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  48. 6.8.5 Nippon Fine Chemical Recent Developments
  49. 6.9 Merck KGaA
  50. 6.9.1 Merck KGaA Company Information
  51. 6.9.2 Merck KGaA Business Overview
  52. 6.9.3 Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  54. 6.9.5 Merck KGaA Recent Developments
  55. 6.10 Genevant Sciences
  56. 6.10.1 Genevant Sciences Company Information
  57. 6.10.2 Genevant Sciences Business Overview
  58. 6.10.3 Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  60. 6.10.5 Genevant Sciences Recent Developments
  61. 6.11 Cytiva
  62. 6.11.1 Cytiva Company Information
  63. 6.11.2 Cytiva Business Overview
  64. 6.11.3 Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  66. 6.11.5 Cytiva Recent Developments
  67. 6.12 Croda International
  68. 6.12.1 Croda International Company Information
  69. 6.12.2 Croda International Business Overview
  70. 6.12.3 Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  72. 6.12.5 Croda International Recent Developments
  73. 6.13 Creative Biolabs
  74. 6.13.1 Creative Biolabs Company Information
  75. 6.13.2 Creative Biolabs Business Overview
  76. 6.13.3 Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  78. 6.13.5 Creative Biolabs Recent Developments
  79. 6.14 Corden Pharma
  80. 6.14.1 Corden Pharma Company Information
  81. 6.14.2 Corden Pharma Business Overview
  82. 6.14.3 Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  84. 6.14.5 Corden Pharma Recent Developments
  85. 6.15 Catalent
  86. 6.15.1 Catalent Company Information
  87. 6.15.2 Catalent Business Overview
  88. 6.15.3 Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  90. 6.15.5 Catalent Recent Developments
  91. 6.16 Acuitas Therapeutics
  92. 6.16.1 Acuitas Therapeutics Company Information
  93. 6.16.2 Acuitas Therapeutics Business Overview
  94. 6.16.3 Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  96. 6.16.5 Acuitas Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country
  2. 7.1.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026)
  4. 7.1.3 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  6. 7.2.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026)
  8. 7.2.3 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country
  2. 8.1.1 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026)
  4. 8.1.3 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  6. 8.2.1 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country
  2. 9.1.1 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  6. 9.2.1 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country
  2. 10.1.1 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026)
  4. 10.1.3 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  6. 10.2.1 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026)
  8. 10.2.3 South America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country
  2. 11.1.1 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  6. 11.2.1 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Value Chain Analysis
  2. 12.1.1 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Mode & Process
  7. 12.2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Distributors
  10. 12.2.3 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst